Petition for Writ of Certiorari — Dan Robert, et al., Petitioners v. Lloyd J. Austin, III, Secretary of Defense, et al.

Supreme Court briefNov 22, 2023

Ask Donna

What actually matters in this document.

Text

No. _________

================================================================================================================

In The

Supreme Court of the United States

---------------------------------♦--------------------------------DAN ROBERT AND HOLLIE MULVIHILL,

Petitioners,

v.

LLOYD J. AUSTIN, IN HIS OFFICIAL CAPACITY

AS SECRETARY OF DEFENSE, U.S. DEPARTMENT

OF DEFENSE, XAVIER BECERRA, IN HIS

OFFICIAL CAPACITY AS SECRETARY OF THE

U.S. DEPARTMENT OF HEALTH AND HUMAN

SERVICES, AND ROBERT CALIFF, IN HIS

OFFICIAL CAPACITY AS COMMISSIONER OF

THE U.S. FOOD AND DRUG ADMINISTRATION,

Respondents.

---------------------------------♦--------------------------------On Petition For A Writ Of Certiorari

To The United States Court Of Appeals

For The Tenth Circuit

---------------------------------♦--------------------------------PETITION FOR A WRIT OF CERTIORARI

---------------------------------♦--------------------------------ANDREW L. SCHLAFLY

939 Old Chester Road

Far Hills, NJ 07931

(908) 719-8608

aschlafly@aol.com

Counsel for Petitioners

================================================================================================================

i

QUESTIONS PRESENTED

1. Whether the unlawful implementation of the

harmful Covid vaccine mandate in the Armed

Services properly evades judicial review based

on repeal of the mandate and separation of a

service member who is subject to recall to duty.

2. Whether it is proper and authorized for a court

of appeals to engage in factfinding, while going

outside of the record, to dismiss service

members’ appeal without reaching its merits.

3. Whether the government may properly force

citizens to receive an experimental genemodifying injection, recognized in the medical

literature as causing severe adverse effects.

ii

PARTIES TO THE PROCEEDINGS

Petitioners, plaintiffs-appellants below, are Dan

Robert and Hollie Mulvihill.

Respondents, defendants-appellees below, are

Lloyd J. Austin, in his official capacity as Secretary of

Defense, U.S. Department of Defense, Xavier

Becerra, in his official capacity as Secretary of the

U.S. Department of Health and Human Services, and

Robert Califf, in his official capacity as Commissioner

of the U.S. Food and Drug Administration.

RELATED PROCEEDINGS

Robert and Mulvihill v. Austin, et al., No. 22-1032,

U.S. Court of Appeals for the Tenth Circuit.

Judgments entered on July 6, 2023 and Aug. 30,

2023.

Robert and Mulvihill v. Austin, et al., No. 21-cv02228-RM-STV, U.S. District Court for the District of

Colorado. Judgment entered on Jan. 11, 2022.

iii

TABLE OF CONTENTS

Pages

QUESTIONS PRESENTED ......................................... i

PARTIES TO THE PROCEEDINGS .......................... ii

RELATED PROCEEDINGS........................................ ii

OPINIONS BELOW .................................................... 1

JURISDICTION .......................................................... 1

STATUTORY PROVISIONS INVOLVED .................. 1

STATEMENT OF THE CASE..................................... 2

A. Factual Background ............................................ 3

B. Proceedings Below............................................... 6

REASONS FOR GRANTING THE PETITION .......... 8

I. There Is Exceptional Importance to

Judicial Review of Unlawful Biological

Injections into Members of the

Armed Services ................................................... 9

A. The Illegality of the Mandate ...................... 10

B. Harm Caused by the Mandate .................... 12

C. Judicial Review of the Life-Changing

mRNA Technology – Never Authorized

by Congress – Was Improperly

Denied ........................................................... 16

II. The Decision Below Creates a Circuit Split

as to the Appropriateness of Appellate

Factfinding Reaching Beyond the Record ....... 18

CONCLUSION .......................................................... 20

iv

APPENDIX CONTENTS

Published Order

Robert v. Austin,

72 F.4th 1160 (10th Cir. 2023) ...................... App. 1

Unpublished Orders

Robert v. Austin, Civil Action

No. 21-cv-02228-RM-STV

(D. Colo. Jan. 11, 2022) .............................. App. 11

Robert v. Austin, Final Judgment

(D. Colo. Jan. 11, 2022) ............................... App. 19

Robert v. Austin, Denial of Rehearing,

No. 22-1032 (10th Cir. Aug. 30, 2023) ......... App. 21

v

TABLE OF AUTHORITIES

Pages

Cases

Anderson v. Bessemer City,

470 U.S. 564 (1985) ....................................... 19

Ass’n for Molecular Pathology v. Myriad

Genetics, Inc., 569 U.S. 576 (2013) ......... 16, 17

Brutsche v. Commissioner,

585 F.2d 436 (10th Cir. 1978) ...................... 19

Church v. Biden, Civ. No. 21-2815 (CKK),

2021 U.S. Dist. LEXIS 215069

(D.D.C. Nov. 8, 2021) ........................................ 7

Feds for Med. Freedom v. Biden,

63 F.4th 366 (5th Cir. 2023) ............................. 8

Freedom Holdings, Inc. v. Cuomo,

624 F.3d 38 (2d Cir. 2010) ............................. 19

Heinold Hog Mkt., Inc. v. Superior Feeders,

Inc., 623 F.2d 636 (10th Cir. 1979) .............. 19

June Med. Servs. L.L.C. v. Russo,

140 S. Ct. 2103 (2020) ................................... 19

McCarty v. McCarty, 453 U.S. 210 (1981) ........... 7

Nat’l Fed’n of Indep. Bus. v. DOL, OSHA,

595 U.S. 109 (2022) ......................................... 8

Robert v. Austin,

72 F.4th 1160 (10th Cir. 2023) ......................... 1

United States v. Soto, 48 F.3d 1415

(7th Cir. 1995)................................................ 19

Zenith Radio Corp. v. Hazeltine Research,

395 U.S. 100 (1969) ....................................... 19

Constitutional Provision and Statutes

U.S. CONST., amend. XIII.................................... 17

vi

U.S. CONST., amend. XIV ...................................... 6

10 U.S.C. §1107....................................... 1, 5, 6, 10

10 U.S.C. §1107a..................................... 2, 5, 6, 10

21 U.S.C. §360bbb-3 ............................................. 2

21 U.S.C. §360bbb-3(e)(1)(A)(ii)(III)..................... 2

28 U.S.C. §1254(1) ................................................ 1

28 U.S.C. §1331..................................................... 6

28 U.S.C. §1346..................................................... 6

28 U.S.C. §1361..................................................... 6

50 U.S.C. §1520..................................................... 6

Other

K. Acevedo-Whitehouse and R. Brunob,

“Potential health risks of mRNA-based vaccine

therapy: A hypothesis,” Med Hypotheses

171:111015 (Feb. 2023)

https://tinyurl.com/y3tn7t79 ......................... 16

Army Center for Synthetic Biology

https://www.arl.army.mil/collaborate-withus/opportunity/army-center-forsynthetic-biology/ ............................................ 16

Army Regulation 40–562,

Medical Services, “Immunizations and

Chemoprophylaxis for the

Prevention of Infectious Diseases”

https://armypubs.army.mil/epubs/DR_pubs/

DR_a/pdf/web/r40_562.pdf .............................. 6

Asst. Secretary of Defense Memorandum,

“Mandatory Vaccination of Service Members

Using the Pfizer-BioNTech COVID-19 and

COMIRNATY COVID-19 Vaccines”

(Sept. 14, 2021) ................................................. 5

vii

Lloyd Austin, Memorandum for Senior

Pentagon Leadership Commanders

of the Combatant Commands Defense

Agency and DOD Field Activity Directors

(Aug. 24, 2021) https://tinyurl.com/2ucrj74j .... 4

Anika Binnendijk, et al., “U.S. Military

Applications and Implications, An Initial

Assessment,” RAND Corporation (2020)

https://www.rand.org/pubs/

research_reports/RR2996.html ...................... 17

David A. Bluemke, M.D., Ph.D., COVID-19

Vaccines and Myocardial Injury,”

308 Radiology No. 3 (Sept. 2023)

https://pubs.rsna.org/doi/10.1148/

radiol.232244 ................................................... 8

Meghan Bowman, “Florida surgeon general

Ladapo suggests link between cardiac

arrest and COVID vaccine” (Aug. 4, 2023)

https://www.wlrn.org/health/2023-08-04/

florida-surgeon-general-ladapo-suggests-linkbetween-cardiac-arrest-and-covid-vaccine ... 13

Natacha Buergin, et al., “Sex-specific

differences in myocardial injury incidence

after COVID-19 mRNA-1273 booster

vaccination,” European Journal of Heart

Failure 1871 (2023)

https://onlinelibrary.wiley.com/doi/epdf/

10.1002/ejhf.2978 ............................................ 13

CDC, “Myocarditis and Pericarditis”

(Nov. 3, 2023) https://www.cdc.gov/

coronavirus/2019ncov/vaccines/safety/myocarditis.html ......... 12

viii

Commissioner of Patents and Trademarks,

Policy Statement on Patentability of

Animals, 1077 Off. Gaz. Pat. Office 24

(April 7, 1987), reprinted in

Donald S. Chisum, Chisum on Patents

app. 24-2 (1998) ............................................. 18

Dept. of the Navy, Bureau of Medicine and

Surgery Memorandum, “Interchangeability

of the FDA-Approved Pfizer-BioNTech

Vaccine COMIRNATY and FDA-Authorized

Pfizer-BioNTech Vaccine Under EUA”

(Sept. 3, 2021) ................................................... 5

Mike Gooding, “Measuring the costs of U.S.

military’s COVID-19 vaccine mandate;

critics say policy harmed force,”

13NewsNow (July 28, 2023)

https://tinyurl.com/2bpph2yw ....................... 10

A. Magnani, “V. BIOTECHNOLOGY AND

MEDICAL DEVICES: 1. Patenting

Lifeforms: a) Chimeras: The Patentability

of Human-Animal Chimeras,” 14 Berkeley

Tech. L.J. 443 (1999) ..................................... 18

James A. Thorp, M.D., et al., “COVID-19

Vaccines: The Impact on Pregnancy

Outcomes and Menstrual Function,”

28 Journal of American Physicians and

Surgeons (No. 1) 28 (Spring 2023)

https://jpands.org/vol28no1/thorp.pdf .......... 15

1

OPINIONS BELOW

The published opinion of the court of appeals from

which this appeal is taken is reported at Robert v.

Austin, 72 F.4th 1160 (10th Cir. 2023), and

reproduced in the appendix hereto (“App.”) at 1-10.

The underlying opinion of the U.S. District Court is

included in the appendix at 11-18. The order by the

court of appeals to deny the petition for rehearing en

banc was issued on August 30, 2023 (App. 21-22).

JURISDICTION

The judgment of the U.S. Court of Appeals for the

Tenth Circuit was entered on July 6, 2023. (App. 110) A timely petition for rehearing en banc was filed,

and then denied on August 30, 2023. (App. 21-22)

The jurisdiction of this Court is invoked pursuant to

28 U.S.C. § 1254(1).

STATUTORY PROVISIONS INVOLVED

10 U.S.C. §1107 requires:

(a) Notice required.

(1) Whenever the Secretary of Defense requests or requires a member of the armed forces to receive an investigational new drug or a

drug unapproved for its applied use, the Secretary shall provide the member with notice containing the information specified in subsection

(d). …

(d) Content of notice. The notice required under subsection (a)(1) shall include the following:

2

(1) Clear notice that the drug being

administered is an investigational new drug or

a drug unapproved for its applied use.

(2) The reasons why the investigational new

drug or drug unapproved for its applied use is

being administered.

(3) Information regarding the possible side

effects of the investigational new drug or drug

unapproved for its applied use, including any

known side effects possible as a result of the

interaction of such drug with other drugs or

treatments being administered to the members

receiving such drug. …

10 U.S.C. §1107a requires:

(a) Waiver by the President.

(1) In the case of the administration of a product authorized for emergency use under section

564 of the Federal Food, Drug, and Cosmetic

Act [21 USCS § 360bbb-3] to members of the

armed forces, the condition described in section

564(e)(1)(A)(ii)(III) of such Act [21 USCS §

360bbb-3(e)(1)(A)(ii)(III)] and required under

paragraph (1)(A) or (2)(A) of such section

564(e), designed to ensure that individuals are

informed of an option to accept or refuse administration of a product, may be waived only

by the President only if the President determines, in writing, that complying with such

requirement is not in the interests of national

security.

STATEMENT OF THE CASE

Petitioners Dan Robert and Hollie Mulvihill were

staff sergeants in the U.S. Army and Marine Corps,

3

respectively, but were driven out by the unlawful

implementation of a mandate by the Biden

Administration to receive the mRNA biological

injection known as the Covid vaccine. This mandate

by the Biden Administration was invalidated by the

Supreme Court with respect to private employers,

and by the Fifth Circuit with respect to government

workers. But Petitioners were denied their day in

court to challenge the illegal implementation of this

mandate against them. Federal law prohibits using

any unlicensed vaccine on service members without

their informed consent and without an express and

timely presidential waiver of service members’ rights,

which were both lacking.

The district court never reached the merits of

Petitioners’

claims,

by

ruling

they

were

nonjusticiable, and then the court of appeals

dismissed their appeal based on mootness by going

outside of the record to engage in factfinding. This

was procedurally improper and substantively

erroneous on an issue of exceptional importance:

unlawful experimentation on members of the Armed

Services with a novel biological agent having

untested long-term side effects and indisputable

short-term, sometimes fatal harm to some recipients.

A.

Factual Background.

On August 24, 2021, as part of a sweeping

program of mandates by the Biden Administration to

impose vaccination by the mRNA product on as many

people as possible, Defendant Lloyd Austin signed an

order requiring “full vaccination of all members of the

Armed Forces under DOD authority on active duty or

4

in the Ready Reserve.”1 This was a command, and

was not optional. Penalties for non-compliance were

not specified but the violation of any higher order by

an enlisted man or woman is subject to harsh

punishment.

Staff sergeants in the U.S. Army and U.S. Marine

Corps, Petitioners Dan Robert and Hollie Mulvihill,

objected, lost opportunities, and ultimately separated

from the military due in large part to this unlawful

order, and at least Robert has remained subject to

recall as most service members are. Both were

harmed by the preclusion of likely advancement in

the military due to this command to take the mRNA

injection.

This vaccine mandate took effect immediately

despite the unavailability of any fully licensed Covid

vaccines; all the available Covid Vaccines were

offered under only the Emergency Use Authorizations

in Investigatory New Drugs (EUA/IND’s). On August

23, 2021, Rear Admiral Denise Hinton, Chief

Scientist of Defendant FDA, sent a letter to Pfizer

advising it that the EUA previously issued by the

FDA for Pfizer-BNT162b2 Covid-19 vaccine (“Pfizer

BNT”) would remain in place due to the

unavailability of any licensed vaccines as required

by applicable statutes.

The FDA’s website and documents listed the

Pfizer-BNT vaccine as being offered under an EUA

1Lloyd

Austin, Memorandum for Senior Pentagon Leadership

Commanders of the Combatant Commands Defense Agency and

DOD

Field

Activity

Directors

(Aug.

24,

2021)

https://tinyurl.com/2ucrj74j (viewed Nov. 17, 2023).

5

rather than fully licensed. The labeling and other

requirements remained unsatisfied and the PfizerBNT vaccine remained an EUA product because the

approved, but not yet licensed, Comirnaty was

unavailable at the relevant time.

Even though it was impossible lawfully to satisfy

the requirement that only fully licensed vaccines be

used – they were unavailable – commanders within

the Department of Defense (“DOD”) swiftly imposed

the mandate using the EUA Pfizer-BNT vaccine that

remained unlicensed by the FDA. Various units

within DOD received guidance that they could

involuntarily vaccinate service members with

unlicensed vaccines, which expanded to a servicewide practice. (See Asst. Secretary of Defense

Memorandum, “Mandatory Vaccination of Service

Members Using the Pfizer-BioNTech COVID-19 and

COMIRNATY COVID-19 Vaccines” (Sept. 14, 2021);

Dept. of the Navy, Bureau of Medicine and Surgery

Memorandum, “Interchangeability of the FDAApproved Pfizer-BioNTech Vaccine COMIRNATY

and FDA-Authorized Pfizer-BioNTech Vaccine Under

EUA” (Sept. 3, 2021).) DOD then administered many

thousands of involuntary inoculations, without the

required informed consent and without using a fully

licensed vaccine as required.

One of the obligations that Defendant Austin has,

under 10 U.S.C. §1107 with respect to use of an

investigational new drug (“IND”) or drug unapproved

for its applied use, is to provide detailed, written

notice to the service member, as quoted supra.

Neither Defendant Austin nor anyone else in the

Biden Administration provided this.

Another

applicable statute, 10 U.S.C. §1107a (also quoted

6

supra), requires nothing less than a written

Presidential waiver of service members’ right to

informed consent, and no such waiver ever occurred.

Petitioners had personally contracted and

recovered

from

Covid-19

infections, thereby

developing natural immunity as demonstrated to or

documented by the military. Army Regulation 40562, “Immunization and Chemoprophylaxis for the

Prevention of Infectious Diseases,”2 presumptively

exempts from any vaccination requirement a service

member that the military knows has had a

documented previous infection.

B. Proceedings Below.

Petitioners Robert and Mulvihill filed their

lawsuit in the U.S. District Court for the District of

Colorado on August 17, 2021, where jurisdiction

existed under 28 U.S.C. §§ 1331, 1346, and 1361. Six

days after Defendant Austin issued his order for the

compulsory Covid vaccination, Petitioners filed on

August 30 their unsuccessful motion for a TRO and

subsequently sought a Preliminary Injunction. After

obtaining leave to amend, they filed their Amended

Complaint on October 6, asserting five causes of

action: violations of (1) the Administrative Procedure

Act, (2) 10 U.S.C. §1107, (3) 10 U.S.C. §1107a, (4) 50

U.S.C. §1520, and (5) the Fourteenth Amendment of

the U.S. Constitution. Plaintiffs further moved for a

preliminary injunction. (Dist. Ct. Dkt. 16)

2 This document is an all-service publication and has an equiva-

lent name for each of the applicable services.

https://armypubs.army.mil/epubs/DR_pubs/

DR_a/pdf/web/r40_562.pdf (viewed Nov. 20, 2023).

7

The district court dismissed the Amended

Complaint in its entirety on January 11, 2022, by

finding the allegations to be non-justiciable, and

likewise denied Plaintiffs’ pending motion for a

preliminary injunction. The district court never

reached the unlawfulness of the implementation of

Defendant Austin’s order, and the ruling below was

not based on any deference to decision-making by the

military. Instead, the district court relied heavily on

a District of Columbia district court decision that had

denied a request for a preliminary injunction, in

Church v. Biden, Civ. No. 21-2815 (CKK), 2021 U.S.

Dist. LEXIS 215069, at *3 (D.D.C. Nov. 8, 2021). But

that other decision did not dismiss service members’

claims, and instead merely denied a request for a

preliminary injunction only because exemption

requests were still pending.

On appeal, the Tenth Circuit never reached the

merits of this case either.

In a published,

precedential decision, a panel of the Tenth Circuit

granted a motion by the government to dismiss the

appeal based on mootness. Rather than remand for

additional factfinding, the appellate court went

outside of the record to incorrectly conclude that

because Petitioners were separated from the Armed

Services, they no longer had a valid claim. This was

false, as separated service members (including

Robert) are subject to recall, and both Petitioners lost

opportunities due to the unlawful implementation of

the vaccine mandate. See, e.g., McCarty v. McCarty,

453 U.S. 210, 222 (1981) (a “retired officer

remains subject to recall to active duty by the

Secretary of the Army at any time”) (inner quotations

omitted). The court of appeals also cited the repeal of

8

the mandate by Congress, but that repeal did not

provide a full remedy for those who, like Petitioners,

had declined to be subjected to the unlawful vaccine

mandate.

REASONS FOR GRANTING THE PETITION

This Court should grant the Petition to address a

matter of exceptional importance: whether a

President may violate federal law to coercively inject

novel biological agents into members of the Armed

Services, and then evade review of it in federal court.

Military enlistment is to defend our country, not to

become guinea pigs for politically motivated biological

mandates that were properly enjoined when applied

against employees of private companies and against

government workers. See Nat’l Fed’n of Indep. Bus.

v. DOL, OSHA, 595 U.S. 109 (2022) (blocking vaccine

mandate against private employers); Feds for Med.

Freedom v. Biden, 63 F.4th 366 (5th Cir. 2023)

(blocking vaccine mandate against government

workers). If our national defense is a matter of

exceptional importance – and it certainly is – then

respecting due process by our enlisted men and

women to protect themselves against invasion of their

bodily integrity to alter their genes is also highly

important.

“Vaccine manufacturers are aware of the adverse

effects of mRNA vaccines,”3 is a candid admission

published recently in a peer reviewed medical journal

3 David A. Bluemke, M.D., Ph.D., COVID-19 Vaccines and Myo-

cardial Injury,” 308 Radiology No. 3, at p. 2 (Sept. 2023)

https://pubs.rsna.org/doi/10.1148/radiol.232244 (viewed Nov. 16,

2023).

9

about the Covid vaccines at issue here. Yet despite

their known adverse effects, these mRNA vaccines

were imposed on our service members in violation of

federal law. These mRNA products were rushed to

implementation and illegally injected without legal

accountability during or after. This was a medical

experiment on a scale larger than anything ever

allowed before in our country, and never authorized

by Congress.

Due process requires meaningful

judicial review for the objecting service members,

including those subject to recall to duty as presented

here.

Yet to deny substantive review of Petitioners’

claims below, the Tenth Circuit went beyond the

record and engaged in appellate factfinding without

any of the procedural protections required in district

court. The Tenth Circuit did so in a published

decision that creates a circuit split concerning

procedure, which is an additional reason for review

by this court. Litigants, and particularly current and

former members of our Armed Services, should be

afforded full due process in district court on a remand

by an appellate court whenever it seeks more

factfinding.

For the foregoing reasons as explained further

below, this Petition should be granted.

I. There Is Exceptional Importance to

Judicial Review of Unlawful Biological

Injections into Members of the Armed Services.

The Biden Administration imposed on members of

the Armed Services injections by a novel mRNA

biological agent. This mandate was enjoined by

federal appellate courts when imposed by President

10

Biden on employees of private companies and on

government workers.

The enlistment men and

women of our military did not waive their relevant

rights under federal law by agreeing to serve, and are

not to be made guinea pigs for what became the

equivalent of a large-scale medical experiment.

A. The Illegality of the Mandate.

The illegality of the implementation of this

mandate against the Armed Services is clear.

Federal law allows compelled vaccination of service

members with an Investigational New Drug or

unlicensed vaccine only when the Secretary of

Defense has complied with all the legal requirements

of 10 U.S.C. §1107 or §1107a. Defendants failed to

thereby comply and there was no such timely waiver,

or waiver of any kind, by the President of the United

States of service members’ right to informed consent

to participate in the largest phase 3 clinical study

ever undertaken in the history of the military. To

this day Defendants refuse to restore unvaccinated

service members without penalty for their personal

decisions to decline the Covid vaccine. “[O]ver 8,300

military service members have been discharged due

to non-compliance,” and “another 19,000 troops

remain unvaccinated.”4

It is exceptionally important that there be redress

and accountability in the courts for the unlawful

mandate that injected a biological agent having life4 Mike Gooding, “Measuring the costs of U.S. military's COVID-

19 vaccine mandate; critics

13NewsNow (July 28, 2023).

(viewed Nov. 18, 2023).

say policy harmed force,”

https://tinyurl.com/2bpph2yw

11

changing characteristics into our service members.

Federal law protects the enlisted, and yet the courts

below avoided addressing the plain violations of

federal law as properly alleged by Petitioners. The

district court prematurely dismissed this case by

finding it to be nonjusticiable, and then the court of

appeals dismissed it by declaring it moot. Both bases

for failing to reach the merits of this case were in

error on a matter of enormous significance: the

personal autonomy of our service members. Due

process should not be denied to them.

None of the traditional deference to military

decision-making applies here. This was a mandate

that was likewise imposed against civilians and

everyone who was allegedly under some authority of

the President. Federal appellate courts properly

enjoined the same mandate against civilians, and for

the same reason should have enjoined this abuse of

power against service members in the Armed Forces.

The order at issue here even implicitly authorized the

use of force against young service members if they

objected to this genetic modification of their bodies by

this biological agent, the novel mRNA technology.

Moreover, the injections imposed had typically not

been fully approved as required.

The decision below denying judicial review is

precedential, and unless reversed will be used to

preclude future review of similar abuses of power. No

one expects the Covid pandemic to have been the last

of its kind. Those who risk their lives in defense of

our country are entitled to redress in the courts

under federal law, with full due process. Upon

revelation that this technology causes fatal heart

conditions and otherwise modifies the recipients’

12

genes, judicial review is essential when any segment

of our population, military or civilian, is subjected to

this. Nothing is more repugnant to our inalienable

rights and God-given liberties than being compelled

to receive a biological agent that transforms our

natural composition. The context of the mandate

shows that this was not a military decision for

national security, and legitimate deference to the

military was never an issue here.

B. Harm Caused by the Mandate.

While the Biden Administration went full tilt into

coercing injection by the mRNA Covid vaccine into

everyone it could possibly coerce, the CDC belatedly

admitted to the severe harm it was causing. By

September 2022, long before the precedential

decision was rendered by the court of appeals below,

the CDC admitted to widely reported, sometimes

fatal adverse effects of the mRNA vaccine mandated

against Petitioners and other service members:

myocarditis, which is a sometimes deadly

inflammation of the heart muscle, and pericarditis,

which is an inflammation of the outer lining of the

heart.5

These side effects particularly harmed healthy

young adults – the same demographic subjected to

the Covid vaccine against the military. Of course the

CDC tried to downplay this side effect for a

government-mandated vaccine, but Florida Surgeon

General Joseph Lapado, M.D., Ph.D., has been more

5 CDC, “Myocarditis and Pericarditis” (Nov. 3, 2023)

https://www.cdc.gov/coronavirus/2019ncov/vaccines/safety/myocarditis.html (viewed Nov. 17, 2023).

13

candid. Among his many public statements warning

against this mRNA vaccine was the following:

Two USC basketball players experience cardiac

arrest in the past year and both almost certainly

were forced or misled into taking a vaccine never

proven to meaningfully benefit young, healthy

people, but definitely proven to cause cardiac

injury.

Meghan Bowman, “Florida surgeon general Ladapo

suggests link between cardiac arrest and COVID

vaccine” (Aug. 4, 2023).6

Now numerous reports confirm this deadly side

effects of this mRNA vaccine on young people who are

in the prime of their life, as our Armed Services

enlisted men and women are. Harvard-trained for

both his M.D. and Ph.D. degrees, Florida Surgeon

General Ladapo has been proven right, and has been

able to speak out because he has independence from

the Biden Administration, in contrast with most

researchers who are beholden for funding on the

National Institutes for Health and other federal

agencies. Lapado cited data compiled by the State of

Florida and a peer-reviewed, published Switzerland

study that indeed confirms that “vaccine-associated

myocardial injury was more common than previously

thought.”7

6 https://www.wlrn.org/health/2023-08-04/florida-surgeon-

general-ladapo-suggests-link-between-cardiac-arrest-and-covidvaccine (viewed Nov. 17, 2023).

7 Natacha Buergin, et al., “Sex-specific differences in myocardial

injury incidence after COVID-19 mRNA-1273 booster vaccination,” European Journal of Heart Failure 1871, 1879 (2023)

14

Similar evidence was presented below, yet never

addressed.

For example, the compelling sworn

affidavit by Lieutenant Colonel Theresa Long, MD,

MPH, FS, is part of the record in this case:

37. I personally observed the most physically fit

female Soldier I have seen in over 20 years in the

Army, go from Collegiate level athlete training for

Ranger School, to being physically debilitated

with cardiac problems, newly diagnosed pituitary

brain tumor, thyroid dysfunction within weeks of

getting vaccinated. Several military physicians

have shared with me their firsthand experience

with a significant increase in the number of young

soldiers with migraines, menstrual irregularities,

cancer, suspected myocarditis and reporting

cardiac symptoms after vaccination. Numerous

soldiers and DOD civilians have told me of how

they were sick, bed-ridden, debilitated, and unable

to work for days to weeks after vaccination. I

believe the illnesses and injuries observed are the

proximate and causal effect of the COVID-19

vaccinations. I have also recently reviewed three

flight crew members’ medical records, all of which

presented with both significant and aggressive

systemic health issues. I cannot attribute

anything other than the COVID-19 vaccines

recently received as the source of these maladies

….

(Appellate Appendix below, 109-10)

This mRNA vaccine has been linked to fertility

and pregnancy problems in young women, and

https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2978

(viewed Nov. 18, 2023).

15

Petitioner Mulvihill was pregnant at the time of this

mandate.

“When normalized by time-available,

doses-given, or number of persons vaccinated, all

COVID-19 vaccine [adverse events] AEs far exceed

the safety signal on all recognized thresholds.

These results necessitate a worldwide moratorium on

the use of COVID-19 vaccines in pregnancy.” James

A. Thorp, M.D., et al., “COVID-19 Vaccines: The

Impact on Pregnancy Outcomes and Menstrual

Function,” 28 Journal of American Physicians and

Surgeons (No. 1) 28 (Spring 2023).8 These experts

pointed out that, other than the politically motivated

Biden Administration, “Governments and public

health agencies worldwide are stepping back from

COVID-19 vaccine mandates and are beginning to

recommend against or even prohibiting COVID-19

mandates and vaccinations for vulnerable groups

such as children, pregnant women, and lactating

women.” Id. at 33.

Studies released this year confirm how improper

this vaccine mandate was from a medical perspective.

As foreign researchers wrote about the Covid vaccine:

Furthermore, despite the assumption that there is

no possibility of genomic integration of

therapeutic synthetic mRNA, only one recent

study has examined interactions between vaccine

mRNA and the genome of transfected cells, and

reported that an endogenous retrotransposon,

LINE-1 is unsilenced following mRNA entry to the

cell, leading to reverse transcription of full length

vaccine mRNA sequences, and nuclear entry. This

finding should be a major safety concern, given

8 https://jpands.org/vol28no1/thorp.pdf (viewed Nov. 18, 2023).

16

the possibility of synthetic mRNA-driven

epigenetic and genomic modifications arising.

K. Acevedo-Whitehouse and R. Brunob, “Potential

health risks of mRNA-based vaccine therapy: A

hypothesis,” Med Hypotheses. 2023 Feb; 171:

111015.9

C. Judicial Review of the Life-Changing

mRNA Technology – Never Authorized by

Congress – Was Improperly Denied.

Defendants alone have control of their own

extensive Covid vaccine data in the military which

continues to be withheld from the public.

Defendants have access to the data about service

members harmed by the Covid vaccine; there is an

Army Center for Synthetic Biology relating to

synthetic biological products, which the mRNA

(vaccine) product at issue here is.10 This mRNA

product makes alterations in the molecular structure

of human deoxyribonucleic acid (DNA) and

ribonucleic acid (RNA), and the Supreme Court has

expressly recognized how harmful that can be.

“Changes in the genetic sequence are called

mutations. … Some mutations are harmless, but

others can cause disease or increase the risk of

disease.” Ass’n for Molecular Pathology v. Myriad

Genetics, Inc., 569 U.S. 576, 582 (2013) (emphasis

added).

9 https://tinyurl.com/y3tn7t79 (viewed Nov. 20, 2023).

10 Army Center for Synthetic Biology

https://www.arl.army.mil/collaborate-with-us/opportunity/armycenter-for-synthetic-biology/ (viewed Nov. 18, 2023).

17

Indeed, this Court’s ruling in Molecular Pathology

foreshadowed the mRNA product here, underscoring

the exceptional importance of this case:

One [product development] method begins with an

mRNA molecule and uses the natural bonding

properties of nucleotides to create a new, synthetic

DNA molecule. … Myriad’s patents would, if valid,

give it the exclusive right to isolate an individual’s

BRCA1 and BRCA2 genes (or any strand of 15 or

more nucleotides within the genes) by breaking

the covalent bonds that connect the DNA to the

rest of the individual’s genome.

Molecular Pathology, 569 U.S. at 582, 585. There

this Court rejected ownership of that genetic

engineering, implying the illegality of forcing anyone

to submit their own bodies to such ownership as at

issue here.

The exceptional importance of this issue is

reinforced by how more biological experimentation on

our service members is in the pipeline.

In

“development [are] implantable neural interfaces able

to transfer data between the human brain and the

digital world … to monitor a soldier’s cognitive

workload ….” Anika Binnendijk, et al., “U.S. Military

Applications

and

Implications,

An

Initial

Assessment,” RAND Corporation (2020) (also

describing a “Silent Talk” neurological program that

has been funded since 2009).11 The U.S. Patent and

Trademark Office has ruled that the Thirteenth

Amendment to the U.S. Constitution prohibits the

issuance of any patent on a human being, and

https://www.rand.org/pubs/research_reports/RR2996.html

(viewed Nov. 17, 2023).

11

18

likewise novel biological agents should not be

imposed by government against anyone. See Thomas

A. Magnani, “V. BIOTECHNOLOGY AND MEDICAL

DEVICES: 1. Patenting Lifeforms: a) Chimeras: The

Patentability of Human-Animal Chimeras,” 14

Berkeley Tech. L.J. 443, 444 (1999) (citing

Commissioner of Patents and Trademarks, Policy

Statement on Patentability of Animals, 1077 Off.

Gaz. Pat. Office 24 (April 7, 1987), reprinted in

Donald S. Chisum, Chisum on Patents app. 24-2

(1998).

This mRNA vaccine was never authorized by

Congress, and this mandate was enjoined by federal

appellate courts with respect to private and

government workers. It is a matter of exceptional

importance whether this mandate was properly

imposed on the Armed Services, and judicial review

of this issue was improperly denied below.

II. The Decision Below Creates a Circuit

Split as to the Appropriateness of Appellate

Factfinding Reaching Beyond the Record.

The published court of appeals decision was based

on erroneous appellate factfinding found nowhere in

the record of this case, and contravened precedent.

This Court, the Tenth Circuit itself, and other circuits

have emphasized that a remand is necessary for

further development of the facts, which was denied to

these service members as Plaintiffs. For example,

prior Tenth Circuit cases held that:

the function of appellate review is to decide

whether the correct rule of law was applied to

the facts found. When there has been an

insufficient development of the facts by the

19

parties, so as to amount to the failure of proof of

either position advanced, then … [a] remand for

further development of the facts must follow.

Heinold Hog Mkt., Inc. v. Superior Feeders, Inc., 623

F.2d 636, 637 (10th Cir. 1979) (emphasis added). See

also Brutsche v. Commissioner, 585 F.2d 436, 443

(10th Cir. 1978) (“Because we are without power to

consider the doctrine of estoppel as an initial trier of

fact, the case is remanded to the Tax Court for

findings of fact from the record ….”).

This Court and other circuits have held likewise.

See, e.g., Zenith Radio Corp. v. Hazeltine Research,

395 U.S. 100, 123 (1969) (“appellate courts must

constantly have in mind that their function is not

to decide factual issues de novo”) (emphasis

added); June Med. Servs. L.L.C. v. Russo, 140 S. Ct.

2103, 2121 (2020) (same); Anderson v. Bessemer City,

470 U.S. 564, 573 (1985) (same); Freedom Holdings,

Inc. v. Cuomo, 624 F.3d 38, 54 (2d Cir. 2010) (same);

United States v. Soto, 48 F.3d 1415, 1421 (7th Cir.

1995) (same).

Finally, the congressional repeal in December

2022 of the mandate does not moot this case, as

service members are long subject to recall and thus

continue to be at risk of retaliation and lost

opportunities due to their objection to the unlawful

vaccine mandate. Factual issues were necessary to

resolve first, which should have happened on a

remand to the district court, rather than close the

courthouse doors entirely to those who served our

country honorable for the benefit of all.

20

The foregoing circuit split, the lack of

congressional authorization for the mandate, and the

incompleteness of its repeal support this Petition.

CONCLUSION

For the foregoing reasons, this Petition for a Writ

of Certiorari should be granted.

Respectfully submitted,

ANDREW L. SCHLAFLY

939 OLD CHESTER ROAD

FAR HILLS, NJ 07931

(908) 719-8608

aschlafly@aol.com

Counsel for Petitioners

Dated: November 22, 2023

i

APPENDIX TABLE OF CONTENTS

Page

Published Order

Robert v. Austin,

72 F.4th 1160 (10th Cir. 2023) ......................... App. 1

Unpublished Orders

Robert v. Austin, Civil Action

No. 21-cv-02228-RM-STV

(D. Colo. Jan. 11, 2022)................................... App. 11

Robert v. Austin, Final Judgment

(D. Colo. Jan. 11, 2022)................................... App. 19

Robert v. Austin, Denial of Rehearing,

No. 22-1032 (10th Cir. Aug. 30, 2023) ............ App. 21

App. 1

PUBLISH

UNITED STATES COURT OF APPEALS

FOR THE TENTH CIRCUIT

-------------------------------------------------------------------------------------------------------------------------------------DAN ROBERT; HOLLIE

MULVIHILL; and other

similarly situated individuals,

Plaintiffs - Appellants,

v.

LLOYD J. AUSTIN, in his

official capacity as Secretary

of Defense, U.S. Department

of Defense; XAVIER

BECERRA, in his official

capacity as Secretary of the

U.S. Department of Health

and Human Services; ROBERT

CALIFF, in his official capacity

as Commissioner of the U.S.

Food and Drug Administration,

No. 22-1032

(D.C. No.

1:21-CV-02228-RM-STV)

(D. Colo.)

Defendants - Appellees.1

--------------------------------------------------------------------------------------------------------------------------------------

1

During the pendency of this appeal, Appellants left active

service in the United States Armed Forces. The original case

caption reflected their previous respective ranks while actively

serving in the military. The updated caption mirrors Robert and

Mulvihill’s new status.

App. 2

-------------------------------------------------------------------------------------------------------------------------------------ORDER

-------------------------------------------------------------------------------------------------------------------------------------(Filed Jul. 6, 2023)

Before HOLMES, Chief Judge, McHUGH, and EID,

Circuit Judges.

-------------------------------------------------------------------------------------------------------------------------------------EID, Circuit Judge.

-------------------------------------------------------------------------------------------------------------------------------------Plaintiff-Appellants Dan Robert and Hollie Mulvihill are former members of the United States Armed

Forces who object to the military’s past COVID-19 vaccination requirement. They sued the Department of

Defense (“DoD”), the Food and Drug Administration,

and the Department of Health and Human Services,

claiming to bring the action on behalf of themselves

and all other similarly situated service members and

alleging that DoD lacked authority to require they receive a COVID-19 vaccine. The district court found

that the allegations were not justiciable, declined to

certify a class, denied a request for costs and attorneys’

fees, and dismissed the complaint. Robert and Mulvihill appealed. Exercising jurisdiction under 28 U.S.C.

§ 1291, we grant the government’s motion to dismiss

this case as moot.2

2

Another jurisdictional hurdle Appellants must clear is Article III standing. But “a federal court has leeway to choose among

threshold grounds for denying audience to a case on the merits.”

App. 3

I.

Appellants object to the military’s previous COVID19 vaccination requirement. When this suit was filed,

Robert was actively serving in the United States

Army and Mulvihill was actively serving in the United

States Marine Corps; both were subjected to the prior

vaccination requirement the time. Following litigation,

the district court dismissed their complaint as nonjusticiable. Appellants timely appealed. But after the

district court made its decision, Robert and Mulvihill

both separated from the Armed Forces. Before oral

argument, the government filed a motion contending that Appellants’ departure from the military moots

this case. The government also believes that legislative

and executive branch action offers another reason this

appeal is moot. On January 10, 2023, in accord with

the National Defense Authorization Act for Fiscal Year

2023, Secretary of Defense Lloyd J. Austin rescinded

the military’s COVID-19 vaccination requirement. Dep’t

of Def., Rescission of August 24, 2021 and November 30,

2021 Coronavirus Disease 2019 Vaccination Requirements for Members of the Armed Forces (Jan. 10, 2023),

available at https://perma.cc/L9L2-PF6F.3

Valenzuela v. Silversmith, 699 F.3d 1199, 1205 (10th Cir. 2012)

(cleaned up). We decline to address standing and resolve this case

on mootness concerns alone. See Dunn v. Austin, No. 22-15286,

2023 WL 2319316, at *1 (9th Cir. Feb. 27, 2023) (holding that

DoD’s rescission of the vaccination requirement mooted an appeal

of the denial of a preliminary injunction); Short v. Berger, No. 2215755, 2023 WL 2258384, at *1 (9th Cir. Feb. 24, 2023) (same).

3

On January 12, 2023, this Court directed the parties to file

simultaneous briefs addressing whether this appeal is moot due

App. 4

II.

“The Constitution gives federal courts the power

to adjudicate only genuine Cases and Controversies.”

Kerr v. Polis, 20 F.4th 686, 692 (10th Cir. 2021) (en

banc) (cleaned up). “This case-or-controversy requirement subsists through all stages of federal judicial proceedings . . . [and] requires a party seeking relief to

have suffered, or be threatened with, an actual injury

traceable to the appellee and likely to be redressed by

a favorable judicial decision by the appeals court.”

Prison Legal News v. Fed. Bureau of Prisons, 944 F.3d

868, 879 (10th Cir. 2019) (cleaned up). “Thus, even where

litigation poses a live controversy when filed, the doctrine requires a federal court to refrain from deciding

it if events have so transpired that the decision will

neither presently affect the parties’ rights nor have a

more-than-speculative chance of affecting them in the

future.” Schell v. OXY USA Inc., 814 F.3d 1107, 1114

(10th Cir. 2016) (cleaned up).

“Mootness is a threshold issue because the existence of a live case or controversy is a constitutional

prerequisite to federal court jurisdiction.” Id. at 1113

(cleaned up). “As Article III requires an actual controversy, we lack subject-matter jurisdiction over a case

that is moot. We review mootness determinations de

novo. A case becomes moot when the issues presented

are no longer live or the parties lack a legally cognizable interest in the outcome.” Smith v. Becerra, 44 F.4th

to the fact that Secretary Austin rescinded the COVID-19 vaccination requirement for military service members.

App. 5

1238, 1247 (10th Cir. 2022) (cleaned up). “The crucial

question is whether granting a present determination

of the issues offered . . . will have some effect in the real

world.” Id. (emphasis added) (cleaned up). “No matter

how vehemently the parties continue to dispute the

lawfulness of the conduct that precipitated the lawsuit,

the case is moot if the dispute is no longer embedded

in any actual controversy about the plaintiffs’ particular legal rights.” Id. (cleaned up).

III.

Robert and Mulvihill sought declaratory and injunctive relief, as well as costs and attorneys’ fees.

Their supplemental briefing before this Court does not

ask for back pay as a form of relief, but refers to Appellants losing opportunities and back wages due to DoD’s

rescinded COVID-19 vaccination requirement.

“We take a claim-by-claim approach to mootness

and must decide whether a case is moot as to each

form of relief sought.” Id. (cleaned up). “The defendant

bears the burden of establishing that a once-live case

has become moot.” Id. (cleaned up). “An injunctive relief claim becomes moot when the plaintiff ’s continued

susceptibility to injury is no longer reasonably certain

or is based on speculation and conjecture.” Id. (cleaned

up). “Similarly, a declaratory relief claim is moot if the

relief would not affect the behavior of the defendant

toward the plaintiff.” Id. (cleaned up).

App. 6

a.

We start with Appellants’ claim for declaratory

relief. Their complaint asked the district court to “declare that any order issued by DoD requiring the Plaintiffs to receive inoculation with COVID-19 vaccines

are per se unlawful.” App’x Vol. I at 30. This claim is

moot for two reasons. First, the claim is moot because

Appellants left military service. Schell, 814 F.3d at

1113 (cleaned up) (“[T]he existence of a live case or controversy is a constitutional prerequisite to federal

court jurisdiction.”). Mulvihill departed military service before oral argument, and Robert’s retirement was

completed shortly thereafter. Appellants cannot be

subjected to any vaccine requirement associated with

service in the military because they no longer serve in

the military. Smith, 44 F.4th at 1247 (cleaned up) (“A

case becomes moot when . . . the parties lack a legally

cognizable interest in the outcome.”). Thus, we lack jurisdiction over Appellants’ moot claim.

Second, Appellants’ claim is also moot because

Congress passed legislation requiring DoD to rescind

the COVID-19 vaccine mandate, and the Secretary of

Defense has since done so. See Dunn v. Austin, No. 2215286, 2023 WL 2319316, at *1 (9th Cir. Feb. 27, 2023);

Short v. Berger, No. 22-15755, 2023 WL 2258384, at *1

(9th Cir. Feb. 24, 2023). Appellants cannot be subject to

a vaccine requirement that no longer exists. Smith, 44

F.4th at 1247 (cleaned up) (“[T]he case is moot if the

dispute is no longer embedded in any actual controversy about the plaintiffs’ particular legal rights.”); see

also Schell, 814 F.3d at 1114 (cleaned up) (“Thus, even

App. 7

where litigation poses a live controversy when filed . . .

a federal court [must] refrain from deciding it if events

have so transpired that the decision will neither presently affect the parties’ rights nor have a more-thanspeculative chance of affecting them in the future.”).

It is true that federal courts recognize two exceptions to the mootness doctrine. “[U]nder the voluntary

cessation exception to mootness, a defendant cannot

automatically moot a case simply by ending its unlawful conduct once sued.” Prison Legal News, 944 F.3d at

880 (cleaned up). We “view voluntary cessation with a

critical eye, lest defendants manipulate jurisdiction to

insulate their conduct from judicial review.” Brown v.

Buhman, 822 F.3d 1151, 1166 (10th Cir. 2016) (cleaned

up). However, “[t]he voluntary cessation exception does

not apply, and a case is moot, if the defendant carries

the formidable burden of showing that it is absolutely

clear the allegedly wrongful behavior could not reasonably be expected to recur.” Prison Legal News, 944 F.3d

at 881 (cleaned up). “Even when a legislative body has

the power to reenact an ordinance or statute, ordinarily an amendment or repeal of it moots a case challenging the ordinance or statute.” Smith, 44 F.4th at 1250

(cleaned up).

The second exception is conduct capable of repetition yet evading review. Fleming v. Gutierrez, 785 F.3d

442, 445 (10th Cir. 2015). “Under this exception, which

courts reserve for exceptional situations, issues under

review are not moot if they (1) evade review because

the duration of the challenged action is too short to be

fully litigated prior to its cessation or expiration, and

App. 8

(2) are capable of repetition, such that there is a reasonable expectation that the same complaining party

will be subjected to the same action again.” Id. (cleaned

up).

Neither mootness exception saves this claim. The

voluntary cessation exception offers Appellants no relief because the government has met its arduous burden of showing the allegedly wrongful behavior could

not reasonably be expected to recur. Prison Legal

News, 944 F.3d at 881. Neither does the capable of

repetition but evading review exception benefit Appellants. The duration of the challenged action—here

DoD’s past vaccine mandate as applied to Robert and

Mulvihill—was not too short to be fully litigated before

its expiration. Fleming, 785 F.3d at 445. Furthermore,

nothing in the record leads to a reasonable expectation

they will be subjected to the same action again. Id. Appellants are no longer actively serving in the military

and the Secretary of Defense has rescinded the challenged policy. This is not the exceptional situation the

exception is designed for. Id.

b.

We turn to Robert and Mulvihill’s injunctive relief

claim. They asked the district court to “[e]njoin [ ] DoD

from vaccinating any service members. . . .” App’x

Vol. I at 31. This claim fares no better than the declaratory relief claim. Congress’s revocation of DoD’s vaccine mandate, and DoD’s implementation of Congress’s

App. 9

instruction, means there is no more vaccine mandate

to enjoin. The claim is therefore moot.

c.

Next, we address Appellants’ request for “costs

and attorneys’ fees.” App’x Vol. I at 31. Robert and

Mulvihill raised the matter below, but failed to discuss

it in their briefing before this Court. “We routinely

have declined to consider arguments that are not

raised, or are inadequately presented, in an appellant’s opening brief. . . .” Schneider v. City of Grand

Junction Police Dep’t, 717 F.3d 760, 773 (10th Cir.

2013) (cleaned up). “Stated differently, the omission of

an issue in an opening brief generally forfeits appellate

consideration of that issue.” Id. (cleaned up). We decline to consider Robert and Mulvihill’s request for

costs and attorneys’ fees.

d.

We finish our review with Appellants’ cursory

mention of lost opportunities and back pay. Robert and

Mulvihill’s supplemental briefing superficially alleges

they “continue to lose opportunities and back[ ]pay”

because of the now-rescinded vaccine mandate. Aplt.

Supp. Br. at 1. But they failed to allege lost opportunities or back pay in the district court. “[A]bsent extraordinary circumstances, arguments raised for the

first time on appeal are waived.” Little v. Budd Co.,

Inc., 955 F.3d 816, 821 (10th Cir. 2020), as corrected

(Apr. 6, 2020). “This is true whether the newly raised

App. 10

argument is a bald-faced new issue or a new theory on

appeal that falls under the same general category as

an argument presented at trial.” Id. (cleaned up). Robert and Mulvihill have waived any argument involving

lost opportunities or back pay.

IV.

We GRANT the government’s motion to dismiss

and DISMISS this appeal as moot.

Entered for the Court

Allison H. Eid

Circuit Judge

App. 11

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF COLORADO

Judge Raymond P. Moore

Civil Action No. 21-cv-02228-RM-STV

DAN ROBERT, SSG, U.S. Army,

HOLLIE MULVIHILL, SSgt, U.S. Marine Corps,

and other similarly situated individuals,

Plaintiffs,

v.

LLOYD AUSTIN, in his official capacity as Secretary

of Defense, U.S. Department of Defense,

XAVIER BACERRA, in his official capacity as

Secretary of the U.S. Department of Health and

Human Services, and

JANET WOODCOCK, in her official capacity as

Acting Commissioner of the U.S. Food and Drug

Administration,

Defendants.

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ORDER

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

(Filed Jan. 11, 2022)

Before the Court are Plaintiffs’ Motion for Preliminary Injunction (ECF No. 30) and Defendants’ Motion

to Dismiss (ECF No. 36), which they have combined

with their Opposition to Plaintiffs’ Motion with the

Court’s permission. Plaintiffs filed a Reply in support

of their Motion (ECF No. 43) and, belatedly, a separate

App. 12

Response to the Motion to Dismiss (ECF No. 46). Defendants then filed a Reply (ECF No. 47) in support of

their Motion. Also pending is a Motion for Leave to File

Amicus Curiae (ECF No. 42), filed by Pritish Vora, “an

individual concerned U.S. citizen” who is not an attorney. For the reasons below, the Court denies Plaintiffs’

Motion, grants Defendants’ Motion, and denies the Motion for Leave.

I.

LEGAL STANDARDS

A. Preliminary Injunction

To obtain injunctive relief, a plaintiff must establish “(1) a substantial likelihood of prevailing on the

merits; (2) irreparable harm unless the injunction is

issued; (3) that the threatened injury outweighs the

harm that the preliminary injunction may cause the

opposing party; and (4) that the injunction, if issued,

will not adversely affect the public interest.” Diné Citizens Against Ruining Our Environment v. Jewell, 839

F.3d 1276, 1281 (10th Cir. 2016) (quotation omitted).

The final two requirements merge when the government is the opposing party. See Nken v. Holder, 556

U.S. 418, 435 (2009). An injunction is an extraordinary

remedy, and therefore the plaintiff must demonstrate

a right to relief that is clear and unequivocal. Schrier

v. Univ. of Colo., 427 F.3d 1253, 1258 (10th Cir. 2005).

The fundamental purpose of preliminary injunctive relief is to preserve the relative positions of the parties

until a trial on the merits can be held. Id.

App. 13

B. Motion to Dismiss

Pursuant to Fed. R. Civ. P. 12(b)(1), a court may

dismiss a complaint for “lack of jurisdiction over the

subject matter.” “The general rule is that subject matter jurisdiction may be challenged by a party or raised

sua sponte by the court at any point in the proceeding.”

McAlester v. United Air Lines, Inc., 851 F.2d 1249, 1252

(10th Cir. 1988). Although the burden of establishing

subject matter jurisdiction is on the party asserting jurisdiction, “[a] court lacking jurisdiction must dismiss

the cause at any stage of the proceeding in which it

becomes apparent that jurisdiction is lacking.” Smith

v. Krieger, 643 F. Supp. 2d 1274, 1289 (D. Colo. 2009)

(quotation omitted).

In evaluating a motion to dismiss under Fed. R.

Civ. P. 12(b)(6), a court must accept as true all wellpleaded factual allegations in the complaint, view those

allegations in the light most favorable to the plaintiff,

and draw all reasonable inferences in the plaintiff’s

favor. Brokers’ Choice of Am., Inc. v. NBC Universal,

Inc., 757 F.3d 1125, 1136 (10th Cir. 2014); Mink v. Knox,

613 F.3d 995, 1000 (10th Cir. 2010). The complaint

must allege a “plausible” right to relief. Bell Atl. Corp.

v. Twombly, 550 U.S. 544, 569 n.14 (2007); see also id.

at 555 (“Factual allegations must be enough to raise a

right to relief above the speculative level.”). Conclusory

allegations are insufficient, Cory v. Allstate Ins., 583

F.3d 1240, 1244 (10th Cir. 2009), and courts “are not

bound to accept as true a legal conclusion couched as a

factual allegation,” Twombly, 550 U.S. at 555 (quotation omitted).

App. 14

C. Leave to File a Brief as Amicus Curiae

Participation as an amicus to brief and argue as a

friend of the court is a privilege within the sound discretion of the courts and is contingent on a finding that

the proffered information of amicus is timely, useful, or

otherwise necessary to the administration of justice.

See United States v. Michigan, 940 F.2d 143, 165 (6th

Cir. 1991).

II.

BACKGROUND

Plaintiffs are members of the military who were

stationed in North Carolina when they brought this action on behalf of themselves as well as all other similarly situated active-duty National Guard and Reserve

service members who are subject to Department of Defense regulations and have been ordered by the Secretary of Defense, Defendant Austin, to take a Covid-19

vaccine. (ECF No. 29 at 1-2.) As “documented survivors

of Covid-19,” they assert that have acquired immunity

that is “at least as effective” as that achieved via vaccination, and they seek temporary and permanent injunctive relief preventing their forced vaccination. (Id.

at 2-3.) In addition to asserting class action allegations, the Amended Complaint asserts claims for (1)

violation of the Administrative Procedure Act, (2) violation of 10 U.S.C. § 1107, (3) violation of 10 U.S.C.

§ 1107a, (4) violation of 50 U.S.C. § 1520, and (5) violation of the Fourteenth Amendment.

App. 15

III. ANALYSIS

As a threshold matter, the Court finds there are

two—and only two—Plaintiffs in this case. Although

the Amended Complaint contains “class action allegations,” the Court has not certified any class, and Plaintiffs have not even filed a motion for class certification.

See Fed. R. Civ. P. 23(c)(1)(A) (“At an early practicable

time after a person sues . . . as a class representative,

the court must determine by order whether to certify

the action as a class action.” (emphasis added)). Plaintiffs’ attempt to incorporate two additional non-parties

via a footnote in their Reply (ECF No. 43 at 5 n.7) is

wholly inadequate. Thus, for present purposes, the

only relevant allegations are those pertaining to Plaintiffs Robert and Mulvihill.

The Court next considers the issues of standing

and ripeness, both in terms of whether Plaintiffs have

established a likelihood of success on the merits and

whether Defendants’ Motion should be granted. “The

doctrines of standing and ripeness substantially overlap in many cases.” S. Utah Wilderness Alliance v.

Palma, 707 F.3d 1143, 1157, (10th Cir. 2013). To satisfy

Article III’s standing requirements, a plaintiff must

show: (1) he has suffered an injury in fact that is (a)

concrete and particularized and (b) actual or imminent, not conjectural or hypothetical; (2) the injury is

fairly traceable to the challenged action of the defendant; and (3) it is likely, as opposed to merely

speculative, that the injury will be redressed by a favorable decision. Id. at 1153. In evaluating ripeness,

often characterized as standing on a timeline, “the

App. 16

central focus is on whether the case involves uncertain

or contingent future events that may not occur as anticipated, or indeed may not occur at all.” Id. at 1158

(quotation omitted).

Defendants assert that Plaintiffs’ claims are not

yet ripe because Plaintiff Robert has requested an exemption from the vaccination requirement, which remains pending, and Plaintiff Mulvihill has sought and

obtained a temporary medical exemption from the vaccination requirement. (ECF No. 36 at 13-14.) Moreover,

they argue, were the exemptions to be denied or expire,

the military has extensive administrative procedures

that offer Plaintiffs multiple opportunities to present

their arguments to their respective branches and allow

for those branches to respond. In response, Plaintiffs

contend that since Defendants control the exemption

process, “[i]t cannot be that [they] get to control the

federal court’s jurisdiction based upon [their] timing of

the exercise of [their] discretion.” (ECF No. 46 at 3,

¶ 5.) However, on the current record, the Court finds

there is no basis to assume that Plaintiffs’ exemptions

will be denied or revoked.

Under similar circumstances in Church v. Biden,

2021 WL 5179215, at *10 (D.D.C. Nov. 8, 2021), the

court concluded that two active-duty Marines’ claims

of harm rested on theories of injury that were speculative and contingent on their pending appeals being denied—an outcome that might never come to pass. In

finding the Marines’ claims nonjusticiable, the Church

court also cited the well-established principle that a

court should not review internal military affairs in the

App. 17

absence of exhaustion of available interservice corrective measures, concluding that “[g]ranting the urgent

injunctive relief sought by the Service Member Plaintiffs would require the Court to adjudicate internal

military affairs before the military chain of command

has had full opportunity to consider the accommodation requests at issue.” Id. at *10-11.

The Court agrees with the rationale in Church and

concludes that Plaintiffs’ claims involve uncertain and

contingent events that may not occur as anticipated.

As noted in the Court’s previous Order, Plaintiffs’ contention that they may be subject to discipline for refusing to take a vaccine appears to be based on nothing

more than speculation. Because Plaintiffs have not established that their claims are justiciable, a fortiori,

they cannot establish a likelihood of success on the

merits or a clear and unequivocal right to injunctive

relief. See id. at *8 (“The merits on which plaintiff must

show a likelihood of success encompass not only substantive theories but also establishment of jurisdiction.” (quotation omitted)). Moreover, in the absence of

a justiciable claim, Defendants are entitled to dismissal of this case.1

1

Separate and apart from this basis for dismissal of Plaintiffs’ claims, the Court notes the complete lack of allegations pertaining to any conduct by Defendants Bacerra and Woodcock,

sued in their official capacities as representatives of the U.S. Department of Health and Human Services and the U.S. Food and

Drug Administration, respectively, that could be deemed to state

a claim against either entity.

App. 18

With respect to the Motion for Leave and the proposed amicus brief proffered by Pritish Vora, the Court

finds the information therein is not useful or otherwise

necessary to the administration of justice, and therefore the Court declines to consider it further.

IV. CONCLUSION

Accordingly, the Court DENIES Plaintiffs’ Motion

for Preliminary Injunction (ECF No. 30), GRANTS Defendants’ Motion to Dismiss (ECF No. 37), and DENIES the Motion for Leave (ECF No. 42). The Clerk is

directed to CLOSE this case.

DATED this 11th day of January, 2022.

BY THE COURT:

/s/ Raymond P. Moore

RAYMOND P. MOORE

United States District Judge

App. 19

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF COLORADO

Civil Action No. 21-cv-02228-RM-STV

DAN ROBERT, SSG, U.S. Army,

HOLLIE MULVIHILL, SSgt, U.S. Marine Corps,

and other similarly situated individuals,

Plaintiffs,

v.

LLOYD AUSTIN, in his official capacity as Secretary

of Defense, U.S. Department of Defense,

XAVIER BACERRA, in his official capacity as

Secretary of the U.S. Department of Health and

Human Services, and

JANET WOODCOCK, in her official capacity as

Acting Commissioner of the U.S. Food and Drug

Administration,

Defendants.

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

FINAL JUDGMENT

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

(Filed Jan. 11, 2022)

In accordance with the orders filed during the pendency of this case, and pursuant to Fed. R. Civ. P. 58(a),

the following Final Judgment is hereby entered.

Pursuant to the Order (Doc. 48) of Judge Raymond

P. Moore entered on January 11, 2022, it is

App. 20

ORDERED that judgment is hereby entered in favor of Defendants Lloyd Austin, Xavier Bacerra, and

Janet Woodcock, and against Plaintiffs Dan Robert,

SSG, and Hollie Mulvihill, SSgt. It is

FURTHER ORDERED that this case is closed.

Dated at Denver, Colorado this 11th day of

January, 2022.

FOR THE COURT:

JEFFREY P. COLWELL, CLERK

s/C. Pearson, Deputy Clerk

App. 21

UNITED STATES COURT OF APPEALS

FOR THE TENTH CIRCUIT

-------------------------------------------------------------------------------------------------------------------------------------DAN ROBERT, SSG, U.S.

Army, et al.,

Plaintiffs - Appellants,

v.

LLOYD J. AUSTIN, in his

official capacity as Secretary

of Defense, U.S. Department

of Defense, et al.,

No. 22-1032

(D.C. No.

1:21-CV-02228-RM-STV)

(D. Colo.)

Defendants - Appellees.

-------------------------------------------------------------------------------------------------------------------------------------ORDER

-------------------------------------------------------------------------------------------------------------------------------------(Filed Aug. 30, 2023)

Before HOLMES, Chief Judge, McHUGH, and EID,

Circuit Judges.

-------------------------------------------------------------------------------------------------------------------------------------Appellants’ petition for rehearing is denied.

The petition for rehearing en banc was transmitted to all of the judges of the court who are in regular

active service. As no member of the panel and no judge

App. 22

in regular active service on the court requested that

the court be polled, that petition is also denied.

Entered for the Court

/s/ Christopher M. Wolpert

CHRISTOPHER M. WOLPERT, Clerk

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.